Health Care: Drugs

Alkermes PLC (ALKS: NASDAQ)

$42.83 1.54 | 3.73%
04/15/14 - 04:00 PM ET
Company Income Statement
Mar 2013 Mar 2012 Mar 2011 Mar 2010
Sales 575.55M 389.98M 186.64M 178.28M
Cost of Sales 138.57M 105.05M 43.53M 24.41M
Gross Operating Profit 436.98M 284.93M 143.11M 153.87M
Selling, General, and Administrative Expenses 125.76M 137.63M 82.85M 76.51M
Research & Development 140.01M 141.89M 97.24M 95.36M
Operating Income before D & A (EBITDA) 171.21M 5.40M -36.98M -18.01M
Depreciation & Amortization 73.75M 93.68M 8.65M 25.03M
Interest Income 841.00K 1.52M 2.73M 4.67M
Other Income - Net 1.78M 484.00K -290.00K -360.00K
Special Income / Charges -3.35M 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 84.44M -86.28M -43.19M -38.73M
Interest Expense 48.99M 28.11M 3.30M 5.97M
Pre-Tax Income 35.44M -114.39M -46.49M -44.70M
Income Taxes 10.46M -714.00K -951.00K -5.08M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 24.98M -113.68M -45.54M -39.63M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 24.98M -113.68M -45.54M -39.63M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 24.98M -113.68M -45.54M -39.63M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
40.63M -113.68M -45.54M -39.63M
Preferred Dividends
Net Income Available To Common 24.98M -113.68M -45.54M -39.63M
Basic EPS from Continuing Ops. 0.19 -0.99 -0.48 -0.42
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 0.19 -0.99 -0.48 -0.42
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 0.19 -0.99 -0.48 -0.42
Basic Normalized Net Income/Share 0.31 -0.99 -0.48 -0.42
EPS fr Continuing Ops. 0.18 -0.99 -0.48 -0.42
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 0.18 -0.99 -0.48 -0.42
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 0.18 -0.99 -0.48 -0.42
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0.30 -0.99 -0.48 -0.42
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ALKS

Latest ALKS Headlines from TheStreet

More Financial News for ALKS

Press Releases for ALKS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter